Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

RxBenefits Survey: Nearly Half of Americans (49%) Have Experienced Challenges Obtaining Specialty Medications

New survey data underscores the challenges posed by the rise of costly specialty drug utilization, and showcases consumer preferences as they relate to medication coverage via an employer-sponsored benefits plan


News provided by

RxBenefits

Aug 24, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


BIRMINGHAM, Ala., Aug. 24, 2021 /PRNewswire-PRWeb/ -- Today, RxBenefits, the employee benefits industry's first and only technology-enabled pharmacy benefits optimizer (PBO), announced results of a new survey designed to better understand consumer use of specialty medications -- as defined as high-cost prescription medications prescribed by a physician used to treat complex, chronic conditions -- as well as preferences around Rx coverage via an employer-sponsored benefits plan. The survey was conducted online within the United States by The Harris Poll on behalf of RxBenefits between June 24-28, 2021, among 2,013 adults ages 18+.

Notably, the survey found that 73% of Americans are currently covered by an employer-provided health benefits plan with prescription drug coverage, with 80% stating it is important that their current or future employer-provided health benefits plan will cover the cost of their -- or their family members -- specialty medications. If coverage is not provided by their employer-provided health benefits plan, more than one in ten Americans say they would involve their company's HR department (16%) or change jobs (11%) to get coverage of their specialty medications.

Knowing consumers are willing to change jobs to secure medication coverage, it's imperative employers identify ways to reduce the cost of pharmacy benefits without reducing value and care for employees.

Post this

With both the cost and utilization of specialty drugs increasing year over year, many employers have begun to evaluate new methods to reduce the growing impact on their healthcare costs. Despite proven successes with utilizing an independent prior authorization program and a variable copay program, two methods increasingly being explored include specialty carve-out, or excluding specialty drugs from the pharmacy benefit altogether.

"Specialty drug utilization continues to increase, and is showing no signs of slowing down. In fact, specialty medication costs accounted for over 50% of the total pharmacy spend incurred in 2020. While specialty carve-out has often been touted as an effective method to contain costs, the approach is not effective for employers and can actually cause severe member and service disruption," said Bryan Statham, Chief Executive Officer, RxBenefits. "In today's market where talent acquisition is highly competitive, it's clear that employers must go beyond simply providing a paycheck to attract and retain talent. Providing a rich benefits package while keeping costs in check is one way to achieve this, which ultimately results in a healthier bottom line and a happier workforce. However, it needn't come at a huge expense to self-funded employers."

Additional survey findings include:

  • Of the 49% of Americans who have experienced challenges or roadblocks obtaining their specialty medications, the top challenge experienced was the overall cost of the medication being too high (24%), followed by 16% stating the medication not being covered by an employer-provided health plan
  • Americans ages 18-44 were more likely than those ages 45+ to say they would change jobs to get coverage if their employer-provided benefits did not cover the cost of their -- or a family member's -- specialty medications (19% vs. 5%)
  • Americans ages 18-44 are more likely than those ages 55+ to say they would involve their company's HR department to gain coverage (21% vs. 10%)

"The results of this survey further showcase just how important medication coverage is to today's consumers. And while the benefits landscape can certainly be complicated, employers need an advocate that watches out for their financial interests as well as the best health of their employees -- someone that helps them understand when something is right and when it's not," said Mark Campbell, PharmD, Vice President of Clinical Solutions for RxBenefits. "That's where a PBO comes into play. At RxBenefits, we are dedicated to helping self-funded employers navigate the complex specialty medication landscape while ensuring their employees have access to the medications and treatments they need. Knowing consumers are willing to change jobs to secure medication coverage, it's imperative employers identify ways to reduce the cost of pharmacy benefits without reducing value and care for employees."

Most employers significantly overpay for pharmacy benefits while receiving suboptimal clinical management and customer service. RxBenefits' PBO model provides benefits consultants and their self-insured employer clients a seat at the negotiating table regardless of their size, a data-driven clinical approach and high-touch, personalized service, substantially reducing costs while increasing value and improving member health. The model reduces pharmacy spend by more than 25% the first year, on average, and insulates the plan against future drivers of trend, like specialty medications.

For more information about RxBenefits and its industry-first PBO model, visit http://www.rxbenefits.com/pbo.

Survey Methodology
This survey was conducted online within the United States by The Harris Poll on behalf of RxBenefits between June 24-28, 2021, among 2,013 adults ages 18+. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact [email protected].

About RxBenefits
RxBenefits is a technology-enabled pharmacy benefits optimizer (PBO) with more than 600 pharmacy pricing, data, and clinical experts working together to deliver prescription benefit savings to employee benefit consultants and their self-insured clients. With nearly 2 million members, RxBenefits brings market-leading purchasing power, independent clinical solutions, and high-touch service to its customers – ensuring that all businesses, regardless of size, can provide an affordable and valuable pharmacy benefit plan to their employees. The company is headquartered in Birmingham, AL. For more details, visit http://www.rxbenefits.com or follow the company on Facebook, Twitter, and LinkedIn.

Media Contact

Cortney Williams, ARPR on behalf of RxBenefits, 855-300-8209, [email protected]

Twitter, Facebook

SOURCE RxBenefits

Related Links

http://www.rxbenefits.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.